The broader markets were subdued today. However, tech stocks Datadog (DDOG), Roku (ROKU) and Fitbit (FIT) gained significantly. Here's why.
Follow all the action from St Mary’s as the holders aim to defend their trophy
Reigning Olympic champion Sofia Goggia continued her remarkable podium-topping season with a back-to-back victory in the second World Cup downhill in Crans-Montana on Saturday.
Iran, the Middle East's worst-hit country from coronavirus, will begin vaccinations in the coming weeks, the country's president says.
James Anderson completed career-best figures in Asian conditions as he continued to set the standard for England, but Sri Lanka posted a strong first-innings score of 381 in Galle. Anderson, England's record wicket-taker, is still raising the bar at the age of 38 and finished with an outstanding return of six for 40 at a venue that is far from a swing bowler's ideal hunting ground. But Anderson has long since become a master of tailoring his skills to the task at hand and dismissed both of Sri Lanka's key men, overnight centurion Angelo Mathews and Niroshan Dickwella eight short of a maiden hundred, as well as tail-ender Suranga Lakmal. Their efforts, combined with a priceless 67 from number eight Dilruwan Perera, meant the tourists were still up against it after 140 overs in the field on a pitch that has surely seen its best batting days. With three for Mark Wood and one for Sam Curran, all 10 wickets fell to seam, leaving spinners Jack Leach and Dom Bess nursing a combined return of nought for 195 in 64 overs. Sri Lanka resumed on 229 for four but saw their platform eroded almost immediately as Anderson and Mathews, the two key figures from Friday's play, faced off again. With the second new ball still hard Anderson had to the tools to conjure some seam movement off the pitch and leapt up for caught behind as his sixth delivery of the morning flicked something on the way through. There was no doubt pad was involved but, when the umpire rejected the appeal, an uncertain Joe Root was persuaded to take a second look with DRS. A tiny spike showed up on UltraEdge leaving Mathews (110) looking aggrieved but England overjoyed. Debutant Ramesh Mendis was unable to wipe away their smiles, gone for a seven-ball duck as he flicked Wood off his pads and Jos Buttler flung himself to intercept the ball as it headed towards fine leg. At that point a sub-300 total still looked possible, but Dickwella would not allow it. He drove well against the pacemen and looked far too assured to let either Bess or Leach cut him short, sweeping and cutting nicely. With Dilruwan offering bright support sticking firm at number eight, Dickwella stamped down English momentum to take the score to 313 for six at lunch. The wicketkeeper passed fifty for the 16th time before the break and moved past his career best of 83 afterwards, and seemed dead set on a maiden hundred. But England hatched a fresh plan and, to no great surprise, it hinged on Anderson's application. Angling the ball across the left-hander with a ring of catchers on the off-side, he drew Dickwella into rash drive that was well tracked by Leach at mid-off. He had fallen eight short and Anderson had his five-for. Suranga Lakmal offered himself up as a willing sixth, flashing his second ball to Zak Crawley at gully. Once again, though, Sri Lanka collected themselves and went again. Dilruwan managed things exceptionally, putting on 49 for the last two wickets before he was last man out, hooking Curran to fine leg.
Spain's fifth seed and former world number one Carolina Marin breezed into the final of badminton's Thailand Open Saturday, beating South Korea's An Se-young 21-19, 21-15.
Ugandan peacekeepers say they killed 189 al-Shabaab fighters in attack on one of their camps in Somalia.
Perth Scorchers are on track to go top of the BBL ladder after imports Jason Roy and Colin Munro helped set Melbourne Stars 183 for victory at the MCG.
British ministers are to discuss on Monday further tightening travel restrictions, the BBC reported on Saturday, adding that people arriving in the country could be required to quarantine in hotels. Prime Minister Boris Johnson told a news conference on Friday that the UK may need to implement further measures to protect its borders from new variants of COVID-19. Britain's current restrictions ban most international travel while new rules introduced earlier in January require a negative coronavirus test before departure for most people arriving, as well as a period of quarantine.
It didn't take long for Madonna's daughter Lourdes Leon to make her presencefelt after joining Instagram.
CNN called out Fox News' Tucker Carlson on Friday for lying that the networkhad removed its COVID-19 tracker after President Joe Biden had taken office.
A new crowdfunding campaign in Malawi has raised $100,000 in a week and helped provide basic equipment and medicines in state hospitals to fight the Covid-19 pandemic.
Saudi Arabia intercepted a "hostile target" over Riyadh on Saturday, said state media in the kingdom which has come under repeated attack from Yemen's Iran-backed Huthi rebels since 2015.
IRVINE, Calif., Jan. 23, 2021 (GLOBE NEWSWIRE) -- Plutos Sama Holdings, Inc. (PSH), is proud to announce the nomination of its Chief Executive Officer, Matthew Browndorf, to receive the 2021 award for Excellence in Entrepreneurship from the Orange County Business Journal. 2020 was an extremely difficult year- not only for the world, but especially for small to mid-sized businesses in the United States and especially in California. As a privately owned and funded private equity company focused on distressed assets – most notably in the United States, Central and Eastern Europe and China -- and highly contested takeovers and turnarounds, 2019 was already a difficult year for PSH in general as the economy was peaking its economic cycle and it was forced to eliminate some of the holdings in its portfolio due to hostile purchases and previous portfolio purchases with representation and warranty breaches--writing off almost eight million ($8,000,000) in assets and fourteen million ($14,000,000) in income for 2020. PSH has backed up its purchases and affiliates even when they go wrong by funding reasonable liabilities for the operating companies even after it had to close them. This can be extremely difficult when the world is facing a global pandemic the likes of COVID19. Even Richard Branson had to sit and watch one of his babies, Virgin Australia, head into insolvency and he held his chin high, said they would be back and stronger then ever, and within the year his team was able to turn it around and get it ready for the 2021 COVID19 recovery. “We have about a 50 percent batting average on our picks which in the Major Leagues would be great, but we welcome the chance to improve that to 70 or 80 percent or progressively selecting higher risk appetite on the winners and lower risk appetite on the losers.” From the #1 fastest growing company in 2017 to one of the Top Places to Work in 2018, PSH saw a massive decline in quality deal flow, work force and operations related to the lack of distressed arbitraged and non-performing portfolio company purchases that hit home in 2019; only to be followed by the complete “shelter in place” COVID19 world of the remote working environment in 2020. 2021 is going to be a great year for those general partners that are in distressed assets, so we are proud we made the turn, and we look forward to rebuilding America and the world one asset at a time. FOR MEDIA CONTACT: email@example.com Plutos Sama Holdings, Inc.Plutos Sama Holdings, Inc. is a private equity company in the business of taking control positions in domestic and international distressed and contentious residential and commercial real estate ventures, micro-lending, securitizations, law firms, restaurants, mortgage servicing platforms, and eSports.For more information, visit www.plutosholdings.com. Certain information set forth in this presentation contains “forward-looking information”, including “future oriented financial information” and “financial outlook”, under applicable securities laws (collectively referred to herein as forward-looking statements). Except for statements of historical fact, information contained herein constitutes forward-looking statements of the Company including with respect to future M&A activity and global growth and completion of the Company’s and its partners projects including any required approvals from the regulatory bodies governing sale and shareholder ratification that are currently underway, in development or otherwise under consideration. Forward-looking statements are provided to allow potential investors the opportunity to understand management’s beliefs and opinions in respect of the future so that they may use such beliefs and opinions as one factor in evaluating an investment. These statements are not guarantees of future performance and undue reliance should not be placed on them.
Police in Moscow on Saturday began detaining supporters of jailed Kremlin critic Alexei Navalny after he called for demonstrations across the country against President Vladimir Putin's rule.
The second World Cup downhill at Kitzbuehel will now be raced on Sunday after bad weather and the state of the course forced its postponement Saturday, a day after two gruesome crashes.
Senior doctors have urged the government to halve the current twelve-week waitbetween doses of the Pfizer/BioNTech Covid-19 vaccine.
(Bloomberg) -- Orange agreed to sell a 50% stake in Orange Concessions to a group of French investors in a deal valuing the fiber-optic network operator at 2.7 billion euros ($3.3 billion.)The buyers include Caisse des Dépôts, CNP Assurances and EDF Invest and the transaction is expected to close by the end of the year, according to a statement. Orange will hold a call option that will allow it to regain control and consolidate Orange Concessions in the future.“Through this partnership, Orange holds the means to pursue the development of fiber in rural areas, by winning new public initiative networks or by participating in market consolidation,” Stéphane Richard, chief executive officer of Orange, said in the statement. “This is a key milestone in the delivery of our Engage 2025 strategic plan.”Orange is one of the world’s leading telecommunications businesses. It has 143,000 employees globally, with 83,000 in France. It had 257 million customers as of Sept. 30, including 212 million mobile customers and 21 million fixed broadband customers.The deal is the latest in a series by French mobile operators for fiber technology as the government encourages its rollout to greater swathes of the population.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
The critically endangered Siamese crocodile has been spotted for only the second time in a decade at Thailand's largest national park, according to photos released on Saturday.
(Bloomberg) -- AstraZeneca Plc’s vaccine won approval from Thailand, becoming the third company to clear regulatory requirements for use in Southeast Asia.Thousands of people in Singapore and Indonesia have already received the Pfizer Inc.-BioNTech SE and Sinovac Biotech Ltd. vaccines, and their neighbors are signing more deals to procure supplies. China is also giving free vaccines to countries like the Philippines and Cambodia.Indonesia, Southeast Asia’s biggest and most populous economy, started its coronavirus vaccination program on Jan. 13, with President Joko Widodo taking the first Sinovac jab as the race to immunize people against Covid-19 gains pace.Wealthier but smaller Singapore -- the first in Southeast Asia to start an official Covid-19 vaccination program -- began inoculating healthcare workers with the Pfizer shot on Dec. 30. Its prime minister got his first dose on Jan. 8 and more than 60,000 individuals have received theirs as of Jan. 22.Strategies are evolving across the region as different supply deals are sealed. In the Philippines, President Rodrigo Duterte says he will take a Russian or Chinese vaccine, but his government’s first approval was for the Pfizer shot and the country says it’s close to a deal with Moderna Inc.Indonesia, which is battling the worst outbreak in Southeast Asia, ended 2020 by switching up who’s on its priority list for shots -- focusing on the elderly first instead of the young as previously announced. It was the earliest in the region to receive a vaccine shipment with a Sinovac supply in December.Some countries are also involved in vaccine development and manufacturing, a testament to the variety of strategies employed by Southeast Asian nations. Here’s how the region of more than 650 million people is dealing with differing fiscal, demographic and distribution challenges in their vaccine strategies.INDONESIASTRATEGY:Indonesia seeks to vaccinate 181.5 million people -- about two-thirds of the population -- by March 2022 and President Widodo has called on the cabinet to complete the program by end-2021.The nation expects its vaccination program to cost more than 73 trillion rupiah ($5.2 billion). It plans to be able to vaccinate 16 million people a month; the initial phase of inoculations will target 1.3 million health workers and 17.4 million public workers nationwide during the first quarter of 2021.The country will offer free vaccines to people. With about 13,000 community health centers and 9,000 hospitals across the country, the government says it will be able complete its targeted vaccination to achieve mass immunity.The world’s fourth most populous nation is banking on both Western and Chinese vaccines, ordering 125.5 million doses from Sinovac, 50 million from AstraZeneca Plc and another 50 million from Novavax Inc., while developing 57.6 million of its own Merah PutihIt is now requesting 108 million free doses from the GAVI alliance, after previously saying it was seeking 54 million from the global vaccine facilityTalks are also on with Pfizer Inc. for 50 million doses and loaned cold storage facilities for the vaccineTIMELINE:January, 2021: Sinovac (More than 132,000 healthcare workers given shots)President Widodo got his first dose of the Sinovac shot on Jan. 13 along with public and army representatives, which kicked off Indonesia’s inoculation programIndonesia gave the first dose to 60,815 people in the first week of its mass inoculation drive. As of Jan. 22, more than 132,000 healthcare workers had been given shotsChina’s Sinovac Biotech shipped 3 million doses of vaccines to the country in December; the local food and drug regulator approved them for emergency use in JanuaryEven before the regulator’s approval, the government started distributing the vaccines to its 34 provinces spread across the world’s largest archipelagoSinovac has shipped raw material for 45 million doses to be manufactured by Indonesia’s PT Bio Farma in January. The state firm aims to produce 24 million doses a monthPT Bio Farma plans to also produce shots for other countries through the Coalition for Epidemic Preparedness Innovations as early as the fourth quarter, according to Indonesia’s state-owned enterprises ministry. Bio Farma will produce 100 million doses a year for CEPI.2Q 2021: AstraZenecaIndonesia will get the AstraZeneca vaccines delivered in stages starting from as early as April through the first quarter of 2022The deal also includes the option for the country to purchase an additional 50 million doses.MALAYSIASTRATEGY:Malaysia’s government aims to get as many people inoculated within a year of getting the first batch of vaccines in February, Science Minister Khairy Jamaluddin said in mid-January.The nation’s vaccination program will focus on healthcare workers, the elderly and those with chronic diseases, while individuals under 60 will get immunized by or after the third quarter, he said, adding the immunization drive will be staggered over 18 months.Malaysia is spending $504 million to buy enough shots to cover 26.5 million people, or about 80% of its population. It will start vaccinations from February, according to Prime Minister Muhyiddin Yassin.The country will have a “slight extra” stockpile of vaccines as only those 18 years old and above will be inoculated. The excess vaccines will be administered to migrant workers, expatriates, and non-Malaysian residents, the cost of which must be borne by their employers.Pfizer vaccines will probably be administered to those in urban areas due to the need for ultra-cold storage, while AstraZeneca vaccines will be deployed to rural areas.Malaysia is set to secure 6.4 million doses of the AstraZeneca vaccine through the Covax facility, and another 6.4 million directly, enough to inoculate 20% of the country’s population, according to the science and technology minister. The first batch is expected in the second quarter of 2021The country in January agreed to buy an additional 12.2 million doses of the Pfizer-BioNTech vaccine, an order that will see Malaysia securing 25 million doses in total of the vaccine. That’s enough to cover 39% of the population, according to the health ministryMalaysia’s Pharmaniaga Bhd. and China’s Sinovac signed an agreement for 14 million dosesThe government is in final negotiations with CanSino Biologics Inc. for 3.5 million doses, and for 6.4 million shots of Russia’s Sputnik V vaccine, Khairy said. The deals will involve local companies that can provide fill-finish manufacturing capacityThe nation is in talks with Moderna and Johnson & Johnson, Khairy saidMalaysia was due to conduct its first vaccine trial involving 3,000 volunteers in late January. It would be a phase-III trial on a vaccine candidate developed by the Institute of Medical Biology Chinese Academy of Medical SciencesMalaysia signed an agreement with China in October to be given priority access to Covid-19 vaccines that China develops.TIMELINE:1Q 2021: PfizerThe government has already secured 12.8 million doses from Pfizer-BioNTech SE in a deal signed in late 2020. The first delivery of the shots is due before the end of February, Khairy saidPfizer will deliver to Malaysia one million doses in the first quarter of 2021, 1.7 million in the second, 5.8 million in the third and 4.3 million in the final three months of the yearThe agreement with Pfizer covers 6.4 million people and is contingent on the vaccine being approved by the U.S. FDA and Malaysia’s regulatorMalaysia has negotiated with Pfizer an option to boost its purchases to cover another 20% of its population1Q 2021: SinovacChina’s Sinovac signed an agreement to supply 14 million doses to Malaysia, which may be ready for distribution by the end of March.MYANMARSTRATEGY:Myanmar expects to start inoculating its nearly 55 million population at the end of January. Frontline health workers and key government officials will be prioritized in the first phase of vaccination, to be followed by vulnerable groups such as those older than 65 years.Myanmar’s Covid vaccination fund now has $267.1 million, and well-wishers continue cash donations, de facto leader Aung San Suu Kyi has said. The government expects more than 40% of Myanmar’s population to be inoculated by the end of this year.The government has also been cooperating with GAVI, the vaccine alliance, to get shots for 20% of its population through the Covax facility.The Southeast Asian nation is also planning to allow the private sector to import WHO-approved vaccines later this year.Other than the AstraZeneca deal it has signed, Myanmar also expects vaccines from Chinese developers to arrive in early 2021, with some doses from the Covax facility expected before April 7.TIMELINE:January, 2021: AstraZenecaMyanmar ordered 30 million doses of the AstraZeneca vaccine produced under license by Serum Institute of India to vaccinate 15 million peopleIt will begin vaccinations by the end of January, with another 1.5 million doses donated by India arriving Jan. 22The rollout will start with 750,000 people.PHILIPPINESSTRATEGY:The Philippines plans to buy 148 million vaccine doses to inoculate up to 70 million people this year, or more than half of its population.The nation is eyeing 82.5 billion pesos ($1.7 billion) in vaccine purchases that it plans to fund with financing from multilateral agencies, state-owned banks and companies and bilateral sources, vaccine czar Carlito Galvez said.A number of mayors in Metropolitan Manila have separately drafted plans to provide shots to their constituents while waiting for guidelines on how local government units can purchase the vaccines, according to Paranaque City Mayor Edwin Olivarez, who also heads the Metro Manila Council of mayors.Priority for vaccinations will be given to medical frontliners and workers in industries deemed critical, including low-income groups and those identified as at risk.The government has signed deals for 30 million doses of the Covovax vaccine from the Serum Institute of India, and for 17 million doses from AstraZenecaIt is also in talks with Pfizer, Johnson & Johnson, Sinovac Biotech and Russia’s Gamaleya research institute, according to GalvezThe Gamaleya National Center of Epidemiology and Microbiology had offered 25 million dosesThe country plans to buy 25 million doses from Sinovac, expecting the first shipment to arrive as early as February. It has allowed the Chinese company to hold clinical trials in the nation for its coronavirus vaccine, which President Duterte prefers to be inoculated with, officials saidThe Philippines is nearing a deal with Moderna for as much as 20 million vaccine doses. A supply deal with Moderna will likely be finished in JanuaryThe nation is also expecting to receive fewer doses from the World Health Organization-backed Covax Facility, Galvez saidChina will also donate 500,000 coronavirus vaccine doses to the PhilippinesPfizer has been approved for emergency use by the local FDA, while Gamaleya, AstraZeneca and Sinovac have applied for the same authorizationIndia-based Bharat Biotech International Ltd. has applied for emergency use authorization in the Philippines for its coronavirus vaccine, ABS-CBN News reported, citing the Food and Drug Administration head.TIMELINE:1Q 2021: Sinovac, Sputnik VVaccinations could start as early as the first quarter of 2021 using Sinovac and Russia’s Sputnik V shots, according to GalvezSinovac, Sputnik V are yet to receive the local FDA approval.May, 2021: AstraZenecaThe country will receive as early as May 2.6 million doses of AstraZeneca vaccines purchased by local companies which pooled about800 million pesos to buy 3 million shots.SINGAPORESTRATEGY:The city-state has set aside roughly S$1 billion ($754 million) for vaccines, tapping the likes of Arcturus Therapeutics Holdings Inc., Moderna Inc., Pfizer and Sinovac for supplies. It estimates it should have enough for its around 5.5 million-strong population by the third quarter of 2021.The city-state is prioritizing healthcare workers, the elderly and those in jobs or settings where risk of a super-spreading event is high -- such as the construction, marine and process sector, including migrant workers. For the elderly, it will begin with seniors aged 70 and above.The allocation of vaccines will largely be based on medical indications, suitability and availability, the health minister said in January.Singapore aims to vaccinate the entire adult population, though this will be voluntary. Vaccines will be free for all Singaporeans and long-term residents.Singapore is on track to have a total of eight vaccination centers by end-February. It is also seeking to set up 36 vaccination centers from February to inoculate its population, according to local mediaIn addition to those listed below, Moderna has concluded an agreement with the Ministry of Health to supply the country with its mRNA-1273 vaccineTIMELINE:4Q 2020: Pfizer (More than 60,000 shots given)Singapore started vaccinations on Dec. 30, 2020Prime Minister Lee Hsien Loong got a first dose of the vaccine on Jan. 8, making him the first member of cabinet to get the coronavirus vaccine shotThousands of frontline staff in the aviation and maritime sectors are in line to get their jabs in JanuaryThe city-state received its first shipment of the Pfizer-BioNTech vaccine on Dec. 21. The shots are the only ones that had been approved by the Health Sciences Authority as of Jan. 22.More than 60,000 individuals have received their first dose of the vaccine as of Jan. 22, including staff working in healthcare, frontline and essential services, as well as staff and senior citizens in nursing homes. Some employees at the National Centre for Infectious Diseases have also received their second dose.Pilot vaccinations for senior citizens to start Jan. 27, and to be scaled up from mid-FebruaryEarly 2021: ArcturusArcturus and Singapore’s Economic Development Board have entered into a supply agreement for the right to buy the ARCT-021 vaccineArcturus may ship the first batch of the Covid-19 vaccine it’s developing with local scientists early 2021Results so far show that the vaccine could be effective as a single dose, the Straits Times reported, citing a professor who co-developed the vaccine with Arcturus.January, 2021: Pfizer (More than 60,000 shots given)More than 60,000 individuals have received their first dose of the vaccine as of Jan. 22, including staff working in healthcare, frontline and essential services, as well as staff and senior citizens in nursing homes. Some employees at the National Centre for Infectious Diseases have also received their second dose.Pilot vaccinations for senior citizens to start Jan. 27, and to be scaled up from mid-FebruaryTHAILANDSTRATEGY:Thailand wants to inoculate about 50% of its population by the end of this year.It has previously said it will allow private companies and hospitals to import and sell Covid-19 vaccinations as long as those shots have been approved by the nation’s Food and Drug Administration.Thailand’s health regulator endorsed AstraZeneca’s vaccine for emergency use, the health minister said on Jan. 21. It’s the first to win approval in Thailand, which also has ordered shots developed by China’s Sinovac Biotech.The Southeast Asian nation plans to distribute shots free of cost, while the imports by private firms would allow those who can afford to pay for inoculations along with non-Thais an alternative pathway to get shots.The government has so far approved plans to purchase a total of 63 million doses and the National Vaccine Institute is in talks with several manufacturers for additional supplies for delivery as early as the first quarter. The orders include the AstraZeneca vaccines, some of which will be produced locally by Siam Bioscience Ltd. through technology transferThe government expects to receive the first batch of the Sinovac vaccine in February, and it expects to roll out locally-produced AstraZeneca shots in MayIt has so far approved the orders of 2 million doses from Sinovac and 61 million doses from AstraZenecaNot wanting to rely solely on inoculations from abroad, Thailand is also developing its own anti-coronavirus shotAn mRNA vaccine research project is set to start the first phase of clinical trials in April and the second phase in June. The vaccines may be available by end-2021 after receiving emergency-use authorizationA DNA vaccine effort by Thailand-based BioNet-Asia is expected to start its first phase of human trials in Australia early 2021.TIMELINE:February, 2021: SinovacThe country has said it plans to roll out 200,000 doses of Sinovac vaccines in February, 800,000 in March, and 1 million in AprilFebruary, 2021: AstraZenecaThailand has an advance agreement with AstraZeneca to secure Covid-19 vaccines, which are expected to be distributed by mid-2021, the prime minister has saidThe government expects 50,000 doses to arrive in FebruaryThe government has ordered 61 million shots. The regulatory nod will also open the door for imports by private Thai companies for administering the doses to people who can afford to payThe country said early January it plans to roll out locally-produced AstraZeneca vaccines in MayUnder agreement with AstraZeneca, Siam Bioscience will produce vaccines at its facilities, and Thailand will receive technology transferThailand will supply coronavirus vaccines at “reasonable prices” to Myanmar, Laos, Cambodia and Vietnam when it begins production, Prayuth said.VIETNAMSTRATEGY:Vietnam is working on developing vaccines and will work with suppliers when vaccines are available, according to a spokeswoman at the foreign affairs ministry.It signed a deal with AstraZeneca to acquire about 30 million doses of the Covid-19 vaccine, Deputy Health Minister Truong Quoc Cuong said during a government briefing in JanuaryIt has also been negotiating to buy vaccines from Pfizer and companies from Russia and China, Cuong saidVietnam has four companies and institutes working on developing vaccines. Nanogen Pharmaceutical Biotechnology began its human vaccine trials Dec. 17. The Institute of Vaccines and Medical Biologicals started human trials Jan. 21, according to the health ministry.TIMELINE:1Q 2021: AstraZenecaUnder the deal with AstraZeneca for about 30 million doses, Vietnam expects to receive vaccines each quarter this year, the deputy health minister said Jan. 4.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Sudanese filmmakers who celebrated the end of stifling restrictions following the ouster of autocrat Omar al-Bashir have won multiple international awards but are yet to enjoy the same recognition at home.